$NLNK Recent News Some of the Nasdaq’s leading lights

New Post Public Reply Private Reply Replies (0) Message Board

Feb 12, 2015 at 11:22 AM

$NLNK Recent News

Some of the Nasdaq’s leading lights have begun to dim 2:03 p.m. Jan. 15, 2015 - The Trading Deck
Leading growth stocks continue to shine 3:08 p.m. Jan. 13, 2015 - The Trading Deck
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com
Longer-term signposts point stocks higher 2:55 p.m. Jan. 5, 2015 - The Trading Deck
S&P 500 ventures under the 50-day average 11:30 a.m. Jan. 5, 2015 - Michael Ashbaugh
If seasonal script plays out, January stocks will be bullish 2:53 p.m. Dec. 29, 2014 - The Trading Deck
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
6 stocks to watch 3:29 p.m. Dec. 10, 2014 - The Trading Deck
Bull trend absorbs latest market whipsaw 11:23 a.m. Dec. 10, 2014 - Michael Ashbaugh
Merck obtains right to experimental Ebola vaccine 11:23 a.m. Nov. 24, 2014 - Peter Loftus
Merck, NewLink to collaborate on Ebola vaccine 7:56 a.m. Nov. 24, 2014 - Ciara Linnane
4 stocks to watch 1:44 p.m. Nov. 19, 2014 - The Trading Deck
Hazmat-suit maker’s shares jump on Ebola orders 11:49 a.m. Oct. 30, 2014 - Russ Britt
Ebola stocks mostly higher after virus confirmed in New York 1:59 p.m. Oct. 24, 2014 - Joseph Adinolfi
NewLink Genetics shares rally 3.4% in premarket trade 7:02 a.m. Oct. 24, 2014 - Tomi Kilgore
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
Ebola-nation travelers to U.S. to be watched 21 days 2:04 p.m. Oct. 22, 2014 - Russ Britt
Fighting Ebola though investing: one firm’s approach 5:43 p.m. Oct. 21, 2014 - Wallace Witkowski
Small victories recorded in fight against Ebola 11:22 a.m. Oct. 20, 2014 - Russ Britt
Sarepta says its Ebola drug has no ill effects 4:28 p.m. Oct. 16, 2014 - Russ Britt

U.S. to pull troops from Ebola zone 3:38 a.m. Feb. 11, 2015 - Seeking Alpha
Interesting NLNK Put And Call Options For March 20th 10:54 a.m. Feb. 4, 2015 - TheStreet.com
Biggest Movers in Healthcare Stocks Now – NBIX IRWD LGND NLNK 12:15 p.m. Jan. 26, 2015 - InvestorPlace.com
TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog 12:00 p.m. Jan. 26, 2015 - Zacks.com
NIH to Start Ebola Vaccine Study With Glaxo, Merck 9:05 a.m. Jan. 23, 2015 - The Wall Street Journal Interactive Edition
Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog 5:50 p.m. Jan. 22, 2015 - Zacks.com
Affymetrix (AFFX) Expands Genotyping Arrays Product Line - Analyst Blog 1:10 p.m. Jan. 12, 2015 - Zacks.com
Biotech Weekly: Lessons Learned From Investing In Ebola Stocks 8:38 a.m. Jan. 12, 2015 - Seeking Alpha
InsiderInsights.com Daily Round Up 1/8/15: CPRX, HCOM, RPXC, ARIS 3:07 a.m. Jan. 10, 2015 - Seeking Alpha
Biogen Reveals Positive Data from Acute Optic Neuritis Study - Analyst Blog 5:35 p.m. Jan. 9, 2015 - Zacks.com
Ebola Vaccines Ready for West Africa Tests This Month, Says WHO 11:05 a.m. Jan. 9, 2015 - The Wall Street Journal Interactive Edition
Ebola Vaccine Tests Resume 10:39 a.m. Jan. 5, 2015 - The Wall Street Journal Interactive Edition
Biggest Movers in Healthcare Stocks Now – NLNK ACHN MNKD VRTX 1:30 p.m. Jan. 2, 2015 - InvestorPlace.com
Hottest Healthcare Stocks Now – ACHN MNKD VRTX NLNK 9:45 a.m. Jan. 2, 2015 - InvestorPlace.com
Scotland confirms Ebola case 1:53 a.m. Dec. 30, 2014 - Seeking Alpha
NewLink and Merck Get a $30M Contract for Ebola Candidate - Analyst Blog 12:00 p.m. Dec. 29, 2014 - Zacks.com
Viral Investing: Ebola Drug Makers' Varied Strategies 3:09 p.m. Dec. 26, 2014 - Investors Business Daily
BARDA awards Ebola vaccine contract to NewLink Genetics 8:44 a.m. Dec. 22, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ACHN EXAS CBPO ABMD 7:30 a.m. Dec. 22, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – NLNK MACK ELGX HZNP 3:00 p.m. Dec. 19, 2014 - InvestorPlace.com

Morning Analysis on Biotech Stocks -- Novavax, Isis Pharma, OPKO Health, Nanosphere, and NewLink Genetics 9:00 a.m. Jan. 20, 2015 - PR Newswire - PRF
Critical Alerts For Ford, BlackBerry, Aegerion Pharmaceuticals, Yahoo! and NewLink Genetics Released By InvestorsObserver 9:31 a.m. Jan. 15, 2015 - PR Newswire - PRF
NewLink Genetics to Present at the 33rd Annual J.P. Morgan Healthcare Conference 5:01 p.m. Jan. 7, 2015 - GlobeNewswire
NewLink Genetics, Merck Collaboration to Manufacture Ebola Vaccine Candidate Supported by $30 Million Government Award 8:01 a.m. Dec. 22, 2014 - GlobeNewswire
Technical Scrutiny on Biotech Stocks - CTI BioPharma, Vertex Pharma, Progenics Pharma, iBio, and NewLink Genetics 8:45 a.m. Dec. 2, 2014 - PR Newswire - PRF
Ebola Stocks on the Rise as Death Toll Hits 5,000 12:28 p.m. Dec. 1, 2014 - ACCESSWIRE
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine 7:31 a.m. Nov. 24, 2014 - GlobeNewswire
Merck and NewLink Genetics Enter Into Licensing and Collaboration Agreement for Investigational Ebola Vaccine 7:31 a.m. Nov. 24, 2014 - BusinessWire - BZX
NewLink Genetics to Participate in the Upcoming Stifel, Jeffries, and Piper Jaffray Healthcare Conferences 7:01 a.m. Nov. 17, 2014 - GlobeNewswire
NewLink Genetics Appoints Thomas P. Monath, M.D. to the Position of Chief Scientific and Chief Operations Officer of BioProtection Systems Corporation, Its Infectious Disease Division 10:07 a.m. Nov. 14, 2014 - GlobeNewswire
Critical Alerts For Noodles & Company, NewLink Genetics, Under Armour, JP Morgan Chase and Baidu Released By InvestorsObserver 9:31 a.m. Nov. 7, 2014 - PR Newswire - PRF
NewLink Genetics Corporation Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 6, 2014 - GlobeNewswire
Heat Biologics Takes a New Approach to Immunotherapy 2:01 p.m. Nov. 3, 2014 - ACCESSWIRE
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 7:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Time Magazine Warns Against Investing In Certain "Ebola Stocks" 8:22 a.m. Oct. 28, 2014 - ACCESSWIRE
NewLink Genetics to Host Its Third Quarter 2014 Earnings Results Conference Call on November 6, 2014 7:01 a.m. Oct. 27, 2014 - GlobeNewswire
Vaccines, Medical Oxygen, and Helping the Ebola Crisis 12:47 p.m. Oct. 21, 2014 - ACCESSWIRE
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 7:22 a.m. Oct. 20, 2014 - eTeligis
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 6:01 a.m. Oct. 20, 2014 - GlobeNewswire
NewLink Genetics Announces Exclusive Worldwide Licensing Agreement for Development of NLG919, an IDO Inhibitor in Phase 1, and Research Collaboration for the Discovery of Next Generation IDO/TDO Inhibitors 6:01 a.m. Oct. 20, 2014 - Marketwired

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

TORRAS Cases Balance Protection with Slim Design for 2026

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...